CenterBook Partners’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.45M | Buy |
1,594,229
+1,122,154
| +238% | +$5.24M | 0.41% | 53 |
|
|
2025
Q1 | $2.59M | Sell |
472,075
-218,002
| -32% | -$1.2M | 0.17% | 159 |
|
|
2024
Q4 | $2.34M | Sell |
690,077
-2,791,929
| -80% | -$9.46M | 0.14% | 186 |
|
|
2024
Q3 | $9.92M | Buy |
3,482,006
+2,016,131
| +138% | +$5.75M | 0.61% | 37 |
|
|
2024
Q2 | $3.3M | Sell |
1,465,875
-77,998
| -5% | -$175K | 0.21% | 189 |
|
|
2024
Q1 | $3.41M | Buy |
1,543,873
+1,433,246
| +1,296% | +$3.17M | 0.24% | 164 |
|
|
2023
Q4 | $260K | Buy |
+110,627
| New | +$260K | 0.03% | 367 |
|